BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27363612)

  • 1. [Current controversies regarding power morcellation and future directions].
    Kerbage Y; Azaïs H; Estevez JP; Merlot B; Collinet P
    Gynecol Obstet Fertil; 2016; 44(7-8):417-23. PubMed ID: 27363612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [How I do… laparoscopic in-bag morcellation of myomas?].
    Chene G; Delacroix C; Lebail Carval K; Chabert P; Mellier G; Lamblin G
    Gynecol Obstet Fertil Senol; 2017 Oct; 45(10):566-570. PubMed ID: 28967600
    [No Abstract]   [Full Text] [Related]  

  • 3. Is Laparoscopic Power Morcellation of Fibroids a Cardinal Sin in 2017?
    Allahbadia GN
    J Obstet Gynaecol India; 2017 Feb; 67(1):1-6. PubMed ID: 28242959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation.
    Tan-Kim J; Hartzell KA; Reinsch CS; O'Day CH; Kennedy JS; Menefee SA; Harrison TA
    Am J Obstet Gynecol; 2015 May; 212(5):594.e1-10. PubMed ID: 25499259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morcellation of occulted sarcomas during laparoscopic myomectomy and hysterectomy for patients with large fibroid uterus.
    Tinelli A; Farghaly SA
    Minerva Ginecol; 2018 Feb; 70(1):84-88. PubMed ID: 28975775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
    Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No. 371-Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy.
    Murji A; Scott S; Singh SS; Bougie O; Leyland N; Laberge PY; Vilos GA
    J Obstet Gynaecol Can; 2019 Jan; 41(1):116-126. PubMed ID: 30580824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue Extraction Techniques During Laparoscopic Uterine Surgery.
    Clark NV; Cohen SL
    J Minim Invasive Gynecol; 2018 Feb; 25(2):251-256. PubMed ID: 28866098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Morcellation Debate: The History and the Science.
    Adelman MR
    Clin Obstet Gynecol; 2015 Dec; 58(4):710-7. PubMed ID: 26512438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Surgery on the Evolution of Uterine Sarcomas.
    Cusidó M; Fargas F; Baulies S; Plana A; Rodríguez I; Tresserra F; Pascual MA; Fábregas R
    J Minim Invasive Gynecol; 2015; 22(6):1068-74. PubMed ID: 26070730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Treatment of Uterine Fibroids Within a Containment System and Without Power Morcellation.
    Kho KA; Brown DN
    Clin Obstet Gynecol; 2016 Mar; 59(1):85-92. PubMed ID: 26670832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morcellation of the Uterus: Is There Any Place?
    Halaska MJ; Gracia M; Laky R; Zapardiel I
    Curr Oncol Rep; 2020 Jun; 22(7):68. PubMed ID: 32514869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Grade Endometrial Stromal Sarcoma Diagnosed 8 Years After Hysterectomy With Morcellation.
    Sanneh A; Murdock T; Wethington SL; Fader AN; Xing D; Beavis AL
    Obstet Gynecol; 2020 Aug; 136(2):365-368. PubMed ID: 32649495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
    Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
    Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
    Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
    J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation.
    Lum DA; Sokol ER; Berek JS; Schulkin J; Chen L; McElwain CA; Wright JD
    J Minim Invasive Gynecol; 2016; 23(4):548-56. PubMed ID: 26827905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations.
    Sizzi O; Manganaro L; Rossetti A; Saldari M; Florio G; Loddo A; Zurawin R; van Herendael B; Djokovic D
    Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():30-38. PubMed ID: 29149644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas.
    Chen Q; Shi H; Lu W; Lu B
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():85-89. PubMed ID: 30245442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contained tissue extraction using power morcellation: prospective evaluation of leakage parameters.
    Cohen SL; Morris SN; Brown DN; Greenberg JA; Walsh BW; Gargiulo AR; Isaacson KB; Wright KN; Srouji SS; Anchan RM; Vogell AB; Einarsson JI
    Am J Obstet Gynecol; 2016 Feb; 214(2):257.e1-257.e6. PubMed ID: 26348384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma.
    Gao Z; Li L; Meng Y
    PLoS One; 2016; 11(2):e0148050. PubMed ID: 26828206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.